Venus Concept ( (VERO) ) has released its Q3 earnings. Here is a breakdown of the information Venus Concept presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Venus Concept Inc. is a global leader in medical aesthetic technology, offering a wide range of minimally invasive and non-invasive aesthetic and hair restoration solutions across over 60 countries.
In its third quarter of 2025, Venus Concept reported a mixed financial performance with a slight increase in energy-based device revenues but an overall decline in total revenue due to challenges in its hair restoration business. The company also announced the FDA clearance of its new Venus NOVA platform, marking a significant step in its R&D strategy.
Key financial highlights include a 2% year-over-year increase in energy-based device sales, while total revenue decreased by 8% compared to the same period last year. The company’s net loss widened to $22.5 million, and its adjusted EBITDA loss increased to $7.8 million. Strategic moves included a significant debt-to-equity exchange, reducing total debt by 24% since the end of 2024.
Despite the challenging macroeconomic environment, Venus Concept remains focused on long-term growth, with plans for a limited commercial launch of the Venus NOVA in the fourth quarter. The company is also actively working to close the sale of its Venus Hair Business, aiming to streamline operations and enhance shareholder value.